Clinical Study
Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas
Table 2
General indications and contraindications of uterine artery embolization in patients with uterine leiomyomas.
| Indications | | (1) Hypermenorrhea and/or dysmenorrhea | | (2) Absence of a malignant tumor in the uterus and lesion in the adnexa | | (3) Absence of a pelvic inflammatory disease | | (4) No childbearing | | Contraindications | | (1) No symptoms | | (2) Large leiomyoma (more than 10 cm in diameter) and/or multiple leiomyomas | | (3) Coexistence of a malignant tumor in the uterus or a lesion in the adnexa | | (4) Active pelvic inflammatory disease | | (5) Hormone therapy (required for 8–12 weeks after the therapy) | | (6) During pregnancy | | (7) Menopause | | (8) Hope of childbearing | | (9) Allergy to iodine | |
|
|
Department of Radiology, National Defense Medical College Hospital, Japan.
|